Characteristic of patients | n | FibroTest AUROC | Lower 95% | Upper 95% | Prevalence advanced fibrosis F2F3F4 |
---|---|---|---|---|---|
All patients | 267 | 0.81 | 0.74 | 0.86 | 0.27 |
Stratified according to Group | |||||
Group 1 | 170 | 0.86 | 0.77 | 0.91 | 0.24 |
Group 2 | 97 | 0.75 | 0.61 | 0.83 | 0.32 |
Stratified according to ALT value | |||||
ALT<50IU/L | 99 | 0.80° | 0.65 | 0.90 | 0.24 |
ALT>= 50 IU/L | 168 | 0.81 | 0.72 | 0.87 | 0.28 |
Stratified according to Alcohol consumption | |||||
<30 g for men and <20 g for female | 243 | 0.82 $ | 0.74 | 0.87 | 0.32 |
30–40 g for men or 20–25 g for female | 24 | 0.71 | 0.66 | 0.84 | 0.24 |
High risk of FibroTest failures excluded | |||||
Gilbert excluded | 263 | 0.82 | 0.75 | 0.88 | 0.26 |
Acute Inflammation excluded | 263 | 0.82 | 0.75 | 0.87 | 0.26 |
Gilbert or Acute Inflammation excluded | 258 | 0.83 | 0.76 | 0.88 | 0.26 |
Quality of biopsy | |||||
<25 mm | 202 | 0.80 * | 0.72 | 0.86 | 0.29 |
>= 25 mm | 65 | 0.85 | 0.66 | 0.94 | 0.20 |
Fragmented | 152 | 0.81 £ | 0.67 | 0.89 | 0.29 |
Not fragmented | 115 | 0.81 | 0.71 | 0.87 | 0.23 |
Patients with 2 biopsies | |||||
First biopsy | 47 | 0.87 | 0.71 | 0.95 | 0.34 |
Second biopsy | 47 | 0.90 | 0.75 | 0.96 | 0.32 |
Mean 2 biopsies | 47 | 0.91 | 0.76 | 0.97 | 0.32 |